DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Schwarz C, Müller T, Lau S, Parasher K, Staab D, Wahn U.
Mepolizumab-a novel option for the treatment of hypereosinophilic syndrome in childhood.
Pediatr Allergy Immunol 2018;
29 (01) 28-33
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.